Cour Pharmaceutical Development Company, Inc.
@courpharma
First-in-class therapies designed to reprogram the immune system
ID: 2290149181
https://courpharma.com/ 13-01-2014 19:59:41
41 Tweet
178 Takipçi
77 Takip Edilen
Join us in welcoming Paul Peloso, MD, as COUR’s CMO. His expertise in late-stage clinical development makes him a great addition to our team as we advance into Phase 2 studies of our potential treatments for #MyastheniaGravis & #Type1Diabetes. Read more: globenewswire.com/en/news-releas…
